Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients
Figure 2.Time-to-event curves through 1-year for selected adverse events according to P2Y12 G52T variant. (A) Major bleeding (BARC≥3). (B) Primary endpoint (myocardial infarction and death).